Clinical Trial Update: Effects on Insulin Resistance With Tadalafil in Type 2 Diabetes - a Double-blind, Placebo-controlled Crossover Study [Phase 2]

View source ↗

Summary

A Phase 2 double-blind, placebo-controlled crossover trial assessing the effects of tadalafil on insulin resistance in adults with Type 2 diabetes.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• TADALAFIL (TADALAFIL)

Snippet

Sponsor: Göteborg University | Conditions: Diabetes Mellitus, Type 2 | Phase 2 | Status: COMPLETED